INIS
cancer
58%
performance
58%
liver
58%
patients
50%
cooperatives
50%
metastases
41%
radioembolization
41%
veins
33%
thrombosis
33%
indicators
25%
hepatomas
16%
multivariate analysis
16%
hazards
16%
range
8%
diseases
8%
comparative evaluations
8%
yttrium 90
8%
Nursing and Health Professions
Patient
100%
Liver Cancer
58%
Hospital
58%
Overall Survival
41%
Metastasis
41%
Radioembolization
41%
Portal Vein Thrombosis
33%
Indicator
25%
Survival Analysis
16%
Survival
16%
Data Base
8%
Diseases
8%
Multivariate Analysis
8%
Proportional Hazards Model
8%
Yttrium 90
8%
Procedures
8%
Medicine and Dentistry
Liver Cancer
58%
Oncology
50%
Overall Survival
41%
Metastatic Carcinoma
41%
Radioembolization
41%
Portal Vein Thrombosis
33%
Indicator
25%
Survival Analysis
16%
Hepatocellular Carcinoma
16%
Survival
16%
Diseases
8%
Multivariate Analysis
8%
Yttrium 90
8%
Hazard Ratio
8%
Proportional Hazards Model
8%
Therapeutic Procedure
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cancer
58%
Overall Survival
41%
Metastasis
41%
Portal Vein Thrombosis
33%
Indicator
25%
Liver Cell Carcinoma
16%
Survival
16%
Diseases
8%
Yttrium 90
8%
Biochemistry, Genetics and Molecular Biology
Overall Survival
41%
Survival
16%
Multivariate Analysis
16%
Data Base
8%
Neuroscience
Metastasis
41%
Survival Analysis
16%